-Apr 162 minPipeline Therapeutics Announces a $1 Billion USD Global Licensing Deal with Janssen Pharma (J&J)Pipeline Therapeutics and Janssen enter into a global licensing deal for PIPE-307. The deal is valued up to $1B USD.
-Apr 156 minSix synthetic biology companies that have made a markPortfolio Company, Ribbon Biolabs featured as one of the top 6 companies making a mark in Synthetic Biology
-Feb 272 minAbsci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership The generative AI drug company ramps up its internal pipeline and R&D portfolio, tapping into European markets, talent, and tech.